Stewardship / Resistance Scan for Feb 17, 2021 umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.
The University of Oxford has launched the first study to assess the safety and immune responses of its Covid-19 vaccine in children and young adults with first vaccinations expected
Rolling reviews of Novavax s COVID-19 vaccine begin across the globe
And the FDA is planning rapid reviews for COVID-19 vaccine boosters
A number of rolling reviews of Novavax’s COVID-19 vaccine – NVX-CoV2373 – have begun with regulatory authorities across the globe, the company announced yesterday.
This includes rolling reviews with the European Medicines Agency (EMA), the US Food and Drug Administration (FDA), the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Health Canada.
In January, Novavax revealed that its vaccine demonstrated an efficacy rate of 89.3%, also finding that the jab is effective against the UK variant.
The phase 3 clinical trial, conducted in partnership with the UK’s Vaccines Task Force, enrolled over 15,000 people aged 18 to 84.